🎬 Think your procedural tip could help others in the field?. Submit it to the Tricks at the BackTable Competition!. 👉 Winning videos will be featured on BackTable+, social media, and win exclusive BackTable gear. First 10 entries receive discount codes for 50% off in the

Liquid embolics can be a life-saving tool to address traumatic hemorrhages in especially coagulopathic patients. Interventional radiologist Dr. Gary Siskin highlights benefits of liquid embolics over coils, including speed of embolization and high packing density. Stream the

Do you have a protocol for post-procedural care and imaging after hepatic lesion ablation? @AsadBaigMD of @columbiaimaging shares his approach. Stream the full-length video episode: Thank you @Medtronic for supporting this episode. #VI528 #HCC #Cancer

The ongoing IGNYTE-3 trial is investigating RP1, an oncolytic virus designed to target advanced melanoma. Dr. Riad Salem discusses the role of interventional oncology in this treatment approach, including identifying accessible lesions, optimizing injection techniques, planning

Hoping to fine tune your radiation segmentectomy? Take a listen to our newest episode of Dosimetry University with Drs. Tyler Sandow, Nima Kokabi, and Kavi Krishnasamy as they break down their technique of choice, optimal lesions to target, real world data, and case studies.

What is the difference between “suspected” and “diagnostic” hepatocellular carcinoma (HCC), and how does this distinction affect treatment planning? Oncologist Dr. Richard Finn explains the circumstances under which treatment can begin for patients with a high suspicion of HCC,

How do you determine which embolic material to use? Interventional radiologist Dr. Gary Siskin explains that several factors must be considered, including the distance between the catheter and the target embolization site, the size of the vessel, and the desired packing density.

Tumor seeding, bleeding, and off-target ablation are potential risks associated with hepatic lesion ablation. @AsadBaigMD discusses strategies to minimize these risks and effective ways to communicate them to patients. Stream the full-length video episode:

While immunotherapy for metastatic melanoma has resulted in impressively durable responses and prolonged survival, resistance to these treatments can occur. Medical oncologist Dr. Sunandana Chandra offers insight into alternative therapies, including targeted treatments,

What is the potential and future of single session Y90? Find out in our third installment of Dosimetry University with Drs. @bayouteazy, Nima Kokabi, and @kavikrishVIR as they discuss workflow, benefits, patient selection, reperfusion and redirection techniques, microcatheters,.

Coordinating multidisciplinary care for hepatocellular carcinoma (HCC) can be challenging. Oncologist Dr. Richard Finn speaks about comprehensive exploration of treatment options, pivoting to different treatment plans after tumor response, and prioritizing patients for

The prognosis for metastatic melanoma has significantly improved over the past two decades. Medical oncologist Dr. Sunandana Chandra provides an overview of the mechanisms behind immunotherapy treatments, highlighting key drugs and important randomized controlled trials. Stream

It's an exciting time for IR training - the pathway is young and constantly changing. What's next for trainees and what should be improved? Join @DigitalAngio, @NLamparello and @GreggKhodorov as they break down key aspects of each training year, what has changed, and what they

Dr. @AsadBaigMD addresses the common fears of ablating hepatic lesions that are located close to the liver capsule, abdominal wall, and gallbladder. From his perspective, hydrodissection is key to ensuring safe technique. Stream the full-length video episode:

🚨The second installment of Dosimetry University is here! . Drs. Sandow, Kokabi, & Krishnasamy compare BSA, MIRD & voxel-based Y90 dosimetry, discuss planar vs. SPECT/CT for lung shunt fractions, and share when to use TACE, SBRT, or ablation. #VI553:

Where do you begin when you suspect a hepatocellular carcinoma (HCC) diagnosis? Oncologist Dr. Richard Finn and interventional radiologist Dr. Julius Chapiro explain the diversity of HCC cases, highlighting useful imaging modalities, biopsies, and staging systems that can guide

🚨Have a great procedural tip or trick? There’s still plenty of time to submit your video to the Tricks at the BackTable competition!. Whether it's a quick technique that saves time or an innovation that’s changed your workflow, we want to hear it. Submit your short (<5 min).

Is ablation an option for hepatic tumors in tricky locations (centrally-located, near vasculature, in the dome)? @AsadBaigMD of @ColumbiaVIR shares his advice for addressing these lesions. Stream the full-length video episode: . Thank you @Medtronic for

New: Dosimetry University is now in session! Our first episode dives into treatment planning, from glass vs resin, angio mapping softwares, tumor dosages, to segmentectomy. Tune in to hear from experts Drs. Tyler Sandow, Nima Kokabi, and host @kavikrishVIR . #VI552:

RT @_backtableMSK: 📢@kavikrishVIR @TheRealDoctorOs @SidpadiaIR highlight key considerations when starting to perform #GAE in office-based l….